In future studies, we will further elucidate the interaction between ADRA1a and SCD1 using more molecular biology experiments, further validate the ADRA1a/AMPK/SCD1 axis by using in vitro experiments, and trace the dynamic changes in lipids in living cells using fluorescence labeling and microscopic observation, in order to fully explain the mechanism of action of leonurine against NAFLD. The gene discussed is ADRA1A; the disease is metabolic dysfunction-associated steatotic liver disease.